When Insurers Acquire Pharmacy Benefit Managers, Medicare Members Could Pay More
Health Insurer Acquisition of PBMs — the Prescription Drug Middlemen — Raised Premiums for Some Part D Beneficiaries
Health Care Payment and Financing
In Their Own Words
Center for Medicare and Medicaid Services: A Notable Success in Trump 2.0
An LDI Fellow Who Helped Architect the ACA Highlights Progress on Primary Care Payment Reform and the Expansion of Site-Neutral Reimbursement Policies
Print:
This First Opinion originally appeared in STAT News on February 9, 2026.
During the first Trump administration, the Food and Drug Administration was widely viewed as a standout agency, enhancing and expediting drug regulation, regulating tobacco and vaping, and addressing food safety.
In the first year of Trump’s second term, the FDA, along with many other health agencies, has become politicized and demoralized. Conversely, the Center for Medicare and Medicaid Services — which oversees $1.7 trillion in outlays for health care services, 24% of the federal budget — has become the shining star.
In 2025, more than 10% of federal workers (300,000) left government service, including more than 10,000 people with STEM doctoral degrees. This administration has fired and driven out skilled, dedicated public servants, and demoralized those who remain. This exodus and other policies have damaged safety, health, finances, and education both in the U.S. and around the world. Health secretary Robert F. Kennedy Jr.’s scientifically unsupported paring down of the childhood vaccine schedule has put American lives at risk. Meanwhile, the departure of 50,000 employees from Veterans Affairs has increased waiting times for veterans seeking care and led to lower quality care by contractors.
In contrast, CMS stands out, making changes and innovating on the essential nonpartisan missions of the agency. Given the crisis status of the health care system, Trump’s CMS deserves recognition. One of us, Ezekiel, helped design the Affordable Care Act in the Obama administration, so that’s really saying something.
Read the full First Opinion here.
Authors
Ezekiel J. Emanuel, MD, PhD
Diane v.S. Levy and Robert M. Levy University Professor, Medical Ethics and Health Policy, Perelman School of Medicine; Diane v.S. Levy and Robert M. Levy University Professor, Health Care Management, Wharton School
Merjan Ozisik, MBE
Research Administrative Coordinator, Department of Medical Ethics and Health Policy, Perelman School of Medicine
More on Health Care Payment and Financing
Hospital Mergers Push Moms on Medicaid Farther for Care
Mergers Change Where Low-Income Women Give Birth—Prompting Calls for Regulators to Weigh Effects on Vulnerable Patients and Safety-Net Systems
Inside Medicare’s Stalled Shift to Value-Based Care
Former CMMI Leader Liz Fowler Cites Rigid Federal Scoring Rules and Bureaucratic Impatience for Pilot Failures
Six Insights on Health Care Affordability From Penn LDI
LDI Fellows’ Research Quantifies the Effects of High Health Care Costs for Consumers and Shines Light on Several Drivers of High U.S. Health Care Costs
Unpacking the Federal Drug Price Reduction Struggle
How Political Rhetoric and Behind-the-Scenes Deal-Making Obscure Who Really Pays – or How Much
Medicaid Financing and the Health Care Safety Net
Preparing for Challenges Ahead